Seeking a better warning sign for dangerous virus after transplants
NCT ID NCT07286461
Summary
This study aims to find better ways to monitor for a dangerous virus called CMV in adults who have received a stem cell transplant. Researchers will track 290 patients to see if measuring different virus markers in the blood (CMV-RNA and TTV-DNA) can more accurately predict when the CMV virus becomes active and requires treatment, compared to the current standard test. The goal is to improve patient monitoring and help doctors decide when to start or stop preventive antiviral medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Heinrich-Heine-Universitaet Duesseldorf
Düsseldorf, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.